Trial of Indole-3-Carbinol and Silibinin
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 32
Summary
- Conditions
- Smoking
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03687073
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Naomi Fujioka, MD Division of Hematology, Oncology and Transplantation, University of Minnesota